Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine

被引：0
|
作者：
Huabin Liang
Min Lee
Xia Jin
机构：
[1] Viral Disease and Vaccine Translational Research Unit,
[2] and Vaccine Centre,undefined
[3] Institut Pasteur of Shanghai,undefined
[4] Chinese Academy of Sciences,undefined
来源：
Cellular & Molecular Immunology | 2016年 / 13卷
关键词：
dengue virus; protective immunity; vaccine; yellow fever;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Flaviviruses comprise approximately 70 closely related RNA viruses. These include several mosquito-borne pathogens, such as yellow fever virus (YFV), dengue virus (DENV), and Japanese encephalitis virus (JEV), which can cause significant human diseases and thus are of great medical importance. Vaccines against both YFV and JEV have been used successfully in humans for decades; however, the development of a DENV vaccine has encountered considerable obstacles. Here, we review the protective immune responses elicited by the vaccine against YFV to provide some insights into the development of a protective DENV vaccine.
引用
收藏
页码：36 / 46
页数：10
相关论文
共 50 条
  • [31] A DNA Vaccine against Yellow Fever Virus: Development and Evaluation
    Maciel, Milton, Jr.
    Pereira Cruz, Fabia da Silva
    Cordeiro, Marli Tenorio
    da Motta, Marcia Archer
    Soares de Melo Cassemiro, Klecia Marilia
    Carvalho Maia, Rita de Cassia
    Bressan Queiroz de Figueiredo, Regina Celia
    Galler, Ricardo
    Freire, Marcos da Silva
    August, Joseph Thomas
    Marques, Ernesto T. A.
    Dhalia, Rafael
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (04):
  • [32] Safety Follow-up of a Dengue Vaccine When Administered Concomitantly with a Yellow Fever Vaccine in Healthy Toddlers in Colombia
    Cortes, Margarita
    Lopez, Pio
    Marquez, Viviana
    Cortes, Carlos
    Toro, Elizabeth
    Noriega, Fernando
    Zambrano, Betzana
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (11) : 1190 - 1191
  • [33] Vaccine Administration Decision Making: The Case of Yellow Fever Vaccine
    Lown, Beth A.
    Chen, Lin H.
    Wilson, Mary E.
    Sisson, Emily
    Gershman, Mark
    Yanni, Emad
    Jentes, Emily S.
    Hochberg, Natasha S.
    Hamer, Davidson H.
    Barnett, Elizabeth D.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) : 837 - 843
  • [34] HIGH GENOMIC STABILITY OF CHIMERIC YELLOW FEVER/DENGUE VACCINE STRAINS PRODUCED IN VITRO
    Girerd-Chambaz, Yves
    Mantel, Nathalie
    Riou, Patrice
    Lang, Jean
    Barban, Veronique
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 153 - 153
  • [35] Is it time for a new yellow fever vaccine?
    Hayes, Edward B.
    VACCINE, 2010, 28 (51) : 8073 - 8076
  • [36] Yellow fever vaccine and egg allergy
    Cancado, Barbara
    Aranda, Caroline
    Mallozi, Marcia
    Weckx, Lily
    Sole, Dirceu
    LANCET INFECTIOUS DISEASES, 2019, 19 (08): : 812 - 812
  • [37] Ovalbumin content in the yellow fever vaccine
    Smith, Derek
    Wong, Priscilla
    Gomez, Robert
    White, Kevin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (05): : 794 - 795
  • [38] The Yellow Fever Vaccine Misadventure of 1942
    Marr, John S.
    Cathey, John T.
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2017, 23 (06): : 651 - 657
  • [39] YELLOW FEVER VACCINE INACTIVATION STUDIES
    BURRUSS, HW
    HARGETT, MV
    PUBLIC HEALTH REPORTS, 1947, 62 (26) : 940 - 956
  • [40] CHM recommendations for yellow fever vaccine
    Reactions Weekly, 2019, 1782 (1) : 2 - 2
12345